BioCentury
ARTICLE | Financial News

UBS, MPM close $471M cancer fund

April 28, 2016 1:12 AM UTC

UBS Group AG (NYSE:UBS) raised $471 million for the UBS Oncology Impact Fund, which will invest in early stage cancer treatments. MPM Capital is collaborating with UBS on the fund. ...